Mogy Joel R Investment Counsel’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-18,605
Closed -$2.71M 125
2017
Q3
$2.71M Hold
18,605
0.45% 49
2017
Q2
$2.42M Buy
18,605
+5
+0% +$613 0.41% 51
2017
Q1
$2.31M Sell
18,600
-300
-2% -$35.9K 0.4% 54
2016
Q4
$2.19M Sell
18,900
-2,750
-13% -$306K 0.4% 56
2016
Q3
$2.26M Sell
21,650
-720
-3% -$77.9K 0.41% 56
2016
Q2
$2.21M Buy
22,370
+800
+4% +$82.8K 0.41% 61
2016
Q1
$2.16M Buy
21,570
+19,540
+963% +$2.01M 0.4% 58
2015
Q4
$2.43K Sell
2,030
-14,070
-87% -$1.63M 0.46% 51
2015
Q3
$1.74M Buy
16,100
+5,090
+46% +$632K 0.34% 60
2015
Q2
$1.27M Buy
11,010
+3,785
+52% +$433K 0.24% 72
2015
Q1
$833K Buy
7,225
+1,875
+35% +$224K 0.16% 89
2014
Q4
$598K Buy
5,350
+2,450
+84% +$258K 0.11% 97
2014
Q3
$275K Buy
+2,900
New +$262K 0.06% 138

Other funds holding CELG

Mogy Joel R Investment Counsel's CELG Position: Q4 2017 in Review

Mogy Joel R Investment Counsel sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 18,605 shares — an estimated $2.71M sold.

Mogy Joel R Investment Counsel first reported a position in CELG in Q3 2014 and held it in 13 quarters. The position peaked at $2.71M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Mogy Joel R Investment Counsel reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Mogy Joel R Investment Counsel sold 18,605 Celgene Corp shares in Q4 2017, an estimated $2.71M.
  • Mogy Joel R Investment Counsel first reported a position in Celgene Corp in Q3 2014 and held it in 13 quarters.
  • Mogy Joel R Investment Counsel's Celgene Corp position peaked at $2.71M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Mogy Joel R Investment Counsel's 13F filing for Q4 2017, filed 7 Feb 2018.